UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tissue factor as a link between inflammation and coagulation

Trends in cardiovascular medicine, 2016-05, Vol.26 (4), p.297-303

2016

Volltextzugriff (PDF)

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction

European heart journal, 2019-10, Vol.40 (40), p.3318-3332

2019

Volltextzugriff (PDF)

Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis

Cardiovascular research, 2022-07, Vol.118 (10), p.2367-2384

2022

Volltextzugriff (PDF)

Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced Myocarditis

Journal of the American College of Cardiology, 2013-11, Vol.62 (19), p.1737-1745

2013

Volltextzugriff (PDF)

Real‐time optical coherence tomography coregistration with angiography in percutaneous coronary intervention–impact on physician decision‐making: The OPTICO‐integration study

Catheterization and cardiovascular interventions, 2018-07, Vol.92 (1), p.30-37

2018

Volltextzugriff (PDF)

Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation

International journal of molecular sciences, 2024-04, Vol.25 (7), p.4109

2024

Volltextzugriff (PDF)

Pleiotropic Effects of PCSK9: Focus on Thrombosis and Haemostasis

Metabolites, 2022-03, Vol.12 (3), p.226

2022

Volltextzugriff (PDF)

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation

Frontiers in immunology, 2022-03, Vol.13, p.844701-844701

2022

Volltextzugriff (PDF)

Role of protease-activated receptors for the innate immune response of the heart

Trends in cardiovascular medicine, 2014-08, Vol.24 (6), p.249-255

2014

Volltextzugriff (PDF)

Letter to the Editor: Tissue factor of endothelial origin: just another brick in the wall?

Trends in cardiovascular medicine, 2017-02, Vol.27 (2), p.155-156

2017

Volltextzugriff (PDF)

Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial

Clinical research in cardiology, 2021-02, Vol.110 (2), p.249-257

2021

Volltextzugriff (PDF)

Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays

Thrombosis research, 2016-03, Vol.139, p.90-97

2016

Volltextzugriff (PDF)

The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications

Current pharmaceutical design, 2016-01, Vol.22 (4), p.472-484

2016

Volltextzugriff (PDF)

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

International journal of molecular sciences, 2023-04, Vol.24 (9), p.7683

2023

Volltextzugriff (PDF)

Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre-RNA Splicing

Journal of medicinal chemistry, 2011-06, Vol.54 (12), p.4172-4186

2011

Volltextzugriff (PDF)

Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes

Cardiovascular diabetology, 2020-02, Vol.19 (1), p.20-20, Article 20

2020

Volltextzugriff (PDF)

PAR-1 contributes to the innate immune response during viral infection

The Journal of clinical investigation, 2013-03, Vol.123 (3), p.1310-1322

2013

Volltextzugriff (PDF)

Treating the Unstable Atherosclerotic Plaque by Targeting Activated Factor X　– Anticoagulation and Beyond

Circulation Journal, 2015/10/23, Vol.79(11), pp.2329-2331

2015

Volltextzugriff (PDF)

Mitral valve leaflet repair with the new PASCAL system: early real-world data from a German multicentre experience

Clinical research in cardiology, 2020-05, Vol.109 (5), p.549-559

2020

Volltextzugriff (PDF)

Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?

European heart journal, 2022-10, Vol.43 (37), p.3575-3577

2022

Volltextzugriff (PDF)

Autoantibodies Targeting AT1- and ETA-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor

International journal of molecular sciences, 2021-12, Vol.23 (1), p.244

2021

Volltextzugriff (PDF)

Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines

Circulation research, 2005-06, Vol.96 (12), p.1233-1239

2005

Volltextzugriff (PDF)

Cell type-specific roles of PAR1 in Coxsackievirus B3 infection

Scientific reports, 2021-07, Vol.11 (1), p.14264-11, Article 14264

2021

Volltextzugriff (PDF)

Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor

Arteriosclerosis, thrombosis, and vascular biology, 2016-06, Vol.36 (6), p.1263-1271

2016

Volltextzugriff (PDF)

The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies

Biomedicines, 2023-05, Vol.11 (5), p.1371

2023

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(198)
Deutsch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tissue factor as a link between inflammation and coagulation

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction

Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis

Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced Myocarditis

Real‐time optical coherence tomography coregistration with angiography in percutaneous coronary intervention–impact on physician decision‐making: The OPTICO‐integration study

Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation

Pleiotropic Effects of PCSK9: Focus on Thrombosis and Haemostasis

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation

Role of protease-activated receptors for the innate immune response of the heart

Letter to the Editor: Tissue factor of endothelial origin: just another brick in the wall?

Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial

Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays

The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre-RNA Splicing

Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes

PAR-1 contributes to the innate immune response during viral infection

Treating the Unstable Atherosclerotic Plaque by Targeting Activated Factor X　– Anticoagulation and Beyond

Mitral valve leaflet repair with the new PASCAL system: early real-world data from a German multicentre experience

Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?

Autoantibodies Targeting AT1- and ETA-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor

Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines

Cell type-specific roles of PAR1 in Coxsackievirus B3 infection

Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor

The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies

Suchergebnisse filtern